Grant: Project Grant - PA: Nutrition, Metabolism and Diabetes
Institut de recherches cliniques de Montréal
$100,000.00
Role of vitamin K-dependent gamma-carboxylation in beta cell and diabetes
EF 2019-20
Résumé
Vitamin K is an essential micronutrient known to regulate the activity of proteins implicated in blood coagulation and mineralized tissues. Recent clinical observations in humans suggest that partial vitamin K deficiency might be linked to the development of diabetes. However, the biological mechanism by which vitamin K may influence diabetes remains unknown. Beta cell is a unique cell type of the pancreas responsible for the production of insulin. Diabetes is caused by a reduction in the number of beta cells or by a decrease in their capacity to secrete insulin. This research project aims at understanding the function of vitamin K-dependent proteins in pancreatic beta cells and its potential link with the development of diabetes. Our approach includes the use of genetically modified mice lacking the components of the vitamin K cycle in pancreatic beta cells. We will analyze these animals to determine the role of vitamin K in protecting beta cells from cell death, and in promoting their proliferation and function. We will also study the interaction between vitamin K and the endoplasmic reticulum stress in human and mouse beta cells. Finally, we will test if vitamin K can improve or prevent diabetes in pre-clinical mouse models. Altogether, these studies will allow us to understand how vitamin K is implicated in the biology of beta cell and how partial vitamin K deficiency contributes to the development of diabetes.
Programme
Project Grant - PA: Nutrition, Metabolism and Diabetes
Bénéficiaire
Emplacement
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
415220
Name
Ferron Mathieu
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Diabetes, Obesity, Lipid & Lipoprotein Disorders
Projecttitle
Role of vitamin K-dependent gamma-carboxylation in beta cell and diabetes
Programtype2
Operating Grants
Orgnameinp2
Institut de recherches cliniques de Montréal
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - PA: Nutrition, Metabolism and Diabetes
Keyworddelim
Diabetes & Beta Cell Dysfunction; Endoplasmic Reticulum; Er Stress; Unfolded Protein Response; Gamma-Carboxylation & Ggcx; Glucose; Il-1 Beta Signaling; Anti-Apoptotic Response To Cytokines; Insulin; Insulin Secretion; Pancreatic Beta Cells & Pancreatic Islets; Protein Folding; Uggt1; Vitamin K; Vitamin K-Dependent Protein
Abstract
Vitamin K is an essential micronutrient known to regulate the activity of proteins implicated in blood coagulation and mineralized tissues. Recent clinical observations in humans suggest that partial vitamin K deficiency might be linked to the development of diabetes. However, the biological mechanism by which vitamin K may influence diabetes remains unknown. Beta cell is a unique cell type of the pancreas responsible for the production of insulin. Diabetes is caused by a reduction in the number of beta cells or by a decrease in their capacity to secrete insulin. This research project aims at understanding the function of vitamin K-dependent proteins in pancreatic beta cells and its potential link with the development of diabetes. Our approach includes the use of genetically modified mice lacking the components of the vitamin K cycle in pancreatic beta cells. We will analyze these animals to determine the role of vitamin K in protecting beta cells from cell death, and in promoting their proliferation and function. We will also study the interaction between vitamin K and the endoplasmic reticulum stress in human and mouse beta cells. Finally, we will test if vitamin K can improve or prevent diabetes in pre-clinical mouse models. Altogether, these studies will allow us to understand how vitamin K is implicated in the biology of beta cell and how partial vitamin K deficiency contributes to the development of diabetes.
Competitiondate
201909
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ferron, Mathieu
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~